CREAL Closes $8.9M Investment Round Led by ZEISS to Advance Vision Care and AR
We’re excited to announce the closing of an $8.9M equity funding round, led by ZEISS with participation from new and existing investors, including members of the UBS private investor network.
The funding will accelerate :
- The launch of a digitized vision care platform powered by CREAL’s light field display, under a licensing agreement with ZEISS.
- The continued miniaturization of our AR light field module, moving closer to integration into lightweight, everyday AR glasses.
This round brings CREAL’s total funding to over $32M, with backing from ZEISS, Swisscom Ventures, Verve Ventures, and DAA Capital Partners, among others.
With this new round, we’re looking forward to bringing our light field technology closer to products’ integration, ultimately enbaling healthier and more natural digital experiences.